nodes	percent_of_prediction	percent_of_DWPC	metapath
Clopidogrel—CYP3A4—bone cancer	0.58	1	CbGaD
Clopidogrel—CYP2B6—Cisplatin—bone cancer	0.0433	0.278	CbGbCtD
Clopidogrel—CYP2B6—Doxorubicin—bone cancer	0.029	0.187	CbGbCtD
Clopidogrel—CYP2C9—Cisplatin—bone cancer	0.0229	0.147	CbGbCtD
Clopidogrel—ABCB1—Cisplatin—bone cancer	0.0222	0.143	CbGbCtD
Clopidogrel—ABCB1—Doxorubicin—bone cancer	0.0149	0.0956	CbGbCtD
Clopidogrel—ABCB1—Methotrexate—bone cancer	0.0144	0.0926	CbGbCtD
Clopidogrel—CYP3A4—Doxorubicin—bone cancer	0.00892	0.0573	CbGbCtD
Clopidogrel—CES1—Irinotecan Pathway—CYP3A4—bone cancer	0.00378	0.0493	CbGpPWpGaD
Clopidogrel—Prasugrel—CYP3A4—bone cancer	0.00366	0.545	CrCbGaD
Clopidogrel—CYP1A2—Lidocaine metabolism—CYP3A4—bone cancer	0.00307	0.0399	CbGpPWpGaD
Clopidogrel—Ticlopidine—CYP3A4—bone cancer	0.00306	0.455	CrCbGaD
Clopidogrel—CES1—Fluoropyrimidine Activity—DHFR—bone cancer	0.00225	0.0293	CbGpPWpGaD
Clopidogrel—P2RY12—Signal amplification—GNA11—bone cancer	0.00217	0.0283	CbGpPWpGaD
Clopidogrel—CYP2B6—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00171	0.0223	CbGpPWpGaD
Clopidogrel—CYP3A5—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00167	0.0218	CbGpPWpGaD
Clopidogrel—CYP2C8—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00145	0.0189	CbGpPWpGaD
Clopidogrel—CYP2B6—Liver X Receptor Pathway—CYP3A4—bone cancer	0.00144	0.0187	CbGpPWpGaD
Clopidogrel—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	0.00138	0.018	CbGpPWpGaD
Clopidogrel—CYP2C19—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00129	0.0168	CbGpPWpGaD
Clopidogrel—ABCB1—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.00127	0.0165	CbGpPWpGaD
Clopidogrel—CES1—E2F transcription factor network—DHFR—bone cancer	0.00119	0.0155	CbGpPWpGaD
Clopidogrel—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.00119	0.0155	CbGpPWpGaD
Clopidogrel—ABCB1—HIF-1-alpha transcription factor network—CITED2—bone cancer	0.00118	0.0154	CbGpPWpGaD
Clopidogrel—CYP2C9—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00118	0.0153	CbGpPWpGaD
Clopidogrel—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	0.00113	0.0147	CbGpPWpGaD
Clopidogrel—CYP1A2—Aflatoxin B1 metabolism—CYP3A4—bone cancer	0.00113	0.0147	CbGpPWpGaD
Clopidogrel—CYP3A5—Irinotecan Pathway—CYP3A4—bone cancer	0.00107	0.014	CbGpPWpGaD
Clopidogrel—CYP1A2—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00101	0.0131	CbGpPWpGaD
Clopidogrel—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000924	0.012	CbGpPWpGaD
Clopidogrel—CYP3A5—Aflatoxin activation and detoxification—CYP3A4—bone cancer	0.000841	0.0109	CbGpPWpGaD
Clopidogrel—CYP2B6—Xenobiotics—CYP3A4—bone cancer	0.000825	0.0108	CbGpPWpGaD
Clopidogrel—CYP3A5—Xenobiotics—CYP3A4—bone cancer	0.000807	0.0105	CbGpPWpGaD
Clopidogrel—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000777	0.0101	CbGpPWpGaD
Clopidogrel—CYP3A5—Tamoxifen metabolism—CYP3A4—bone cancer	0.000776	0.0101	CbGpPWpGaD
Clopidogrel—P2RY12—G alpha (i) signalling events—RGS1—bone cancer	0.00077	0.01	CbGpPWpGaD
Clopidogrel—P2RY12—G alpha (i) signalling events—GRM4—bone cancer	0.00077	0.01	CbGpPWpGaD
Clopidogrel—CYP2B6—Metapathway biotransformation—CYP4V2—bone cancer	0.000736	0.00959	CbGpPWpGaD
Clopidogrel—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000731	0.00952	CbGpPWpGaD
Clopidogrel—CYP3A5—Metapathway biotransformation—CYP4V2—bone cancer	0.000719	0.00937	CbGpPWpGaD
Clopidogrel—CYP2C8—Xenobiotics—CYP3A4—bone cancer	0.000699	0.0091	CbGpPWpGaD
Clopidogrel—ABCB1—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.000693	0.00903	CbGpPWpGaD
Clopidogrel—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000682	0.00888	CbGpPWpGaD
Clopidogrel—CYP2C8—Tamoxifen metabolism—CYP3A4—bone cancer	0.000672	0.00875	CbGpPWpGaD
Clopidogrel—CES1—E2F transcription factor network—PLAU—bone cancer	0.000662	0.00862	CbGpPWpGaD
Clopidogrel—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000637	0.00829	CbGpPWpGaD
Clopidogrel—CYP2C19—Xenobiotics—CYP3A4—bone cancer	0.000624	0.00812	CbGpPWpGaD
Clopidogrel—CYP2C8—Metapathway biotransformation—CYP4V2—bone cancer	0.000623	0.00812	CbGpPWpGaD
Clopidogrel—CYP2C19—Tamoxifen metabolism—CYP3A4—bone cancer	0.0006	0.00781	CbGpPWpGaD
Clopidogrel—CYP1A2—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000581	0.00757	CbGpPWpGaD
Clopidogrel—CYP2C9—Xenobiotics—CYP3A4—bone cancer	0.000569	0.00741	CbGpPWpGaD
Clopidogrel—CYP2B6—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000567	0.00738	CbGpPWpGaD
Clopidogrel—CYP2C19—Metapathway biotransformation—CYP4V2—bone cancer	0.000556	0.00724	CbGpPWpGaD
Clopidogrel—CYP3A5—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000554	0.00721	CbGpPWpGaD
Clopidogrel—CYP2C9—Tamoxifen metabolism—CYP3A4—bone cancer	0.000547	0.00712	CbGpPWpGaD
Clopidogrel—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000544	0.00709	CbGpPWpGaD
Clopidogrel—CES1—E2F transcription factor network—RB1—bone cancer	0.000544	0.00709	CbGpPWpGaD
Clopidogrel—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.00054	0.00703	CbGpPWpGaD
Clopidogrel—CYP1A2—Estrogen metabolism—CYP3A4—bone cancer	0.000529	0.00689	CbGpPWpGaD
Clopidogrel—CYP2C9—Metapathway biotransformation—CYP4V2—bone cancer	0.000507	0.00661	CbGpPWpGaD
Clopidogrel—CYP1A2—Aflatoxin activation and detoxification—CYP3A4—bone cancer	0.000506	0.0066	CbGpPWpGaD
Clopidogrel—CES1—Fluoropyrimidine Activity—TP53—bone cancer	0.000502	0.00654	CbGpPWpGaD
Clopidogrel—CES1—NRF2 pathway—TGFBR2—bone cancer	0.000496	0.00646	CbGpPWpGaD
Clopidogrel—CES1—NRF2 pathway—GSTP1—bone cancer	0.000496	0.00646	CbGpPWpGaD
Clopidogrel—P2RY12—Platelet activation, signaling and aggregation—SPARC—bone cancer	0.000494	0.00643	CbGpPWpGaD
Clopidogrel—CYP1A2—Xenobiotics—CYP3A4—bone cancer	0.000486	0.00633	CbGpPWpGaD
Clopidogrel—CYP1A2—Tamoxifen metabolism—CYP3A4—bone cancer	0.000467	0.00609	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR ligand binding—GRM4—bone cancer	0.000466	0.00607	CbGpPWpGaD
Clopidogrel—P2RY12—Platelet activation, signaling and aggregation—GNA11—bone cancer	0.000452	0.00588	CbGpPWpGaD
Clopidogrel—CYP1A2—Metapathway biotransformation—CYP4V2—bone cancer	0.000433	0.00564	CbGpPWpGaD
Clopidogrel—CYP2C19—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000428	0.00558	CbGpPWpGaD
Clopidogrel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00042	0.00547	CbGpPWpGaD
Clopidogrel—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000418	0.00544	CbGpPWpGaD
Clopidogrel—P2RY12—Platelet activation, signaling and aggregation—IL3—bone cancer	0.00041	0.00533	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR ligand binding—GRM1—bone cancer	0.000404	0.00526	CbGpPWpGaD
Clopidogrel—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000398	0.00519	CbGpPWpGaD
Clopidogrel—CYP2C9—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.00039	0.00509	CbGpPWpGaD
Clopidogrel—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000372	0.00485	CbGpPWpGaD
Clopidogrel—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000343	0.00446	CbGpPWpGaD
Clopidogrel—CYP2B6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000338	0.00441	CbGpPWpGaD
Clopidogrel—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000335	0.00436	CbGpPWpGaD
Clopidogrel—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000334	0.00436	CbGpPWpGaD
Clopidogrel—CYP3A5—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000331	0.00431	CbGpPWpGaD
Clopidogrel—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000318	0.00414	CbGpPWpGaD
Clopidogrel—Paraesthesia—Cisplatin—bone cancer	0.000317	0.00175	CcSEcCtD
Clopidogrel—Upper respiratory tract infection—Methotrexate—bone cancer	0.000317	0.00175	CcSEcCtD
Clopidogrel—Eosinophilia—Epirubicin—bone cancer	0.000316	0.00174	CcSEcCtD
Clopidogrel—Liver function test abnormal—Doxorubicin—bone cancer	0.000315	0.00174	CcSEcCtD
Clopidogrel—Dyspnoea—Cisplatin—bone cancer	0.000315	0.00174	CcSEcCtD
Clopidogrel—Pancreatitis—Epirubicin—bone cancer	0.000313	0.00173	CcSEcCtD
Clopidogrel—Abdominal pain upper—Doxorubicin—bone cancer	0.000312	0.00172	CcSEcCtD
Clopidogrel—Angina pectoris—Epirubicin—bone cancer	0.000311	0.00172	CcSEcCtD
Clopidogrel—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.000308	0.0017	CcSEcCtD
Clopidogrel—Bronchitis—Epirubicin—bone cancer	0.000307	0.00169	CcSEcCtD
Clopidogrel—Pneumonia—Methotrexate—bone cancer	0.000306	0.00169	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Cisplatin—bone cancer	0.000305	0.00168	CcSEcCtD
Clopidogrel—Depression—Methotrexate—bone cancer	0.000303	0.00167	CcSEcCtD
Clopidogrel—Pancytopenia—Epirubicin—bone cancer	0.000303	0.00167	CcSEcCtD
Clopidogrel—Gastritis—Doxorubicin—bone cancer	0.000302	0.00167	CcSEcCtD
Clopidogrel—Pain—Cisplatin—bone cancer	0.000302	0.00167	CcSEcCtD
Clopidogrel—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.000301	0.00166	CcSEcCtD
Clopidogrel—Renal failure—Methotrexate—bone cancer	0.000299	0.00165	CcSEcCtD
Clopidogrel—Neutropenia—Epirubicin—bone cancer	0.000298	0.00165	CcSEcCtD
Clopidogrel—Abdominal distension—Doxorubicin—bone cancer	0.000297	0.00164	CcSEcCtD
Clopidogrel—Upper respiratory tract infection—Epirubicin—bone cancer	0.000297	0.00164	CcSEcCtD
Clopidogrel—Stomatitis—Methotrexate—bone cancer	0.000296	0.00164	CcSEcCtD
Clopidogrel—Conjunctivitis—Methotrexate—bone cancer	0.000296	0.00163	CcSEcCtD
Clopidogrel—Asthma—Doxorubicin—bone cancer	0.000295	0.00163	CcSEcCtD
Clopidogrel—Eosinophilia—Doxorubicin—bone cancer	0.000292	0.00161	CcSEcCtD
Clopidogrel—Feeling abnormal—Cisplatin—bone cancer	0.000291	0.00161	CcSEcCtD
Clopidogrel—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.00029	0.00378	CbGpPWpGaD
Clopidogrel—Haematuria—Methotrexate—bone cancer	0.00029	0.0016	CcSEcCtD
Clopidogrel—Pancreatitis—Doxorubicin—bone cancer	0.000289	0.0016	CcSEcCtD
Clopidogrel—Angina pectoris—Doxorubicin—bone cancer	0.000288	0.00159	CcSEcCtD
Clopidogrel—Hepatobiliary disease—Methotrexate—bone cancer	0.000288	0.00159	CcSEcCtD
Clopidogrel—Epistaxis—Methotrexate—bone cancer	0.000287	0.00158	CcSEcCtD
Clopidogrel—CYP2C8—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000286	0.00373	CbGpPWpGaD
Clopidogrel—Pneumonia—Epirubicin—bone cancer	0.000286	0.00158	CcSEcCtD
Clopidogrel—P2RY12—GPCR ligand binding—SMO—bone cancer	0.000285	0.00371	CbGpPWpGaD
Clopidogrel—Bronchitis—Doxorubicin—bone cancer	0.000284	0.00157	CcSEcCtD
Clopidogrel—Agranulocytosis—Methotrexate—bone cancer	0.000284	0.00157	CcSEcCtD
Clopidogrel—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.000282	0.00156	CcSEcCtD
Clopidogrel—Pancytopenia—Doxorubicin—bone cancer	0.00028	0.00155	CcSEcCtD
Clopidogrel—Renal failure—Epirubicin—bone cancer	0.00028	0.00154	CcSEcCtD
Clopidogrel—Body temperature increased—Cisplatin—bone cancer	0.000279	0.00154	CcSEcCtD
Clopidogrel—Neuropathy peripheral—Epirubicin—bone cancer	0.000279	0.00154	CcSEcCtD
Clopidogrel—CYP2B6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000278	0.00362	CbGpPWpGaD
Clopidogrel—Stomatitis—Epirubicin—bone cancer	0.000277	0.00153	CcSEcCtD
Clopidogrel—Urinary tract infection—Epirubicin—bone cancer	0.000277	0.00153	CcSEcCtD
Clopidogrel—Conjunctivitis—Epirubicin—bone cancer	0.000277	0.00153	CcSEcCtD
Clopidogrel—Neutropenia—Doxorubicin—bone cancer	0.000276	0.00152	CcSEcCtD
Clopidogrel—Upper respiratory tract infection—Doxorubicin—bone cancer	0.000274	0.00152	CcSEcCtD
Clopidogrel—Haemoglobin—Methotrexate—bone cancer	0.000274	0.00151	CcSEcCtD
Clopidogrel—CYP1A2—Estrogen Receptor Pathway—JUN—bone cancer	0.000274	0.00357	CbGpPWpGaD
Clopidogrel—Hepatitis—Methotrexate—bone cancer	0.000273	0.00151	CcSEcCtD
Clopidogrel—Haemorrhage—Methotrexate—bone cancer	0.000273	0.00151	CcSEcCtD
Clopidogrel—CYP3A5—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000272	0.00354	CbGpPWpGaD
Clopidogrel—Haematuria—Epirubicin—bone cancer	0.000271	0.0015	CcSEcCtD
Clopidogrel—Urinary tract disorder—Methotrexate—bone cancer	0.00027	0.00149	CcSEcCtD
Clopidogrel—Hepatobiliary disease—Epirubicin—bone cancer	0.000269	0.00149	CcSEcCtD
Clopidogrel—Epistaxis—Epirubicin—bone cancer	0.000268	0.00148	CcSEcCtD
Clopidogrel—Urethral disorder—Methotrexate—bone cancer	0.000268	0.00148	CcSEcCtD
Clopidogrel—Sinusitis—Epirubicin—bone cancer	0.000267	0.00147	CcSEcCtD
Clopidogrel—Agranulocytosis—Epirubicin—bone cancer	0.000266	0.00147	CcSEcCtD
Clopidogrel—Pneumonia—Doxorubicin—bone cancer	0.000265	0.00146	CcSEcCtD
Clopidogrel—P2RY12—GPCR downstream signaling—GRM4—bone cancer	0.000263	0.00343	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR downstream signaling—RGS1—bone cancer	0.000263	0.00343	CbGpPWpGaD
Clopidogrel—Visual impairment—Methotrexate—bone cancer	0.000263	0.00145	CcSEcCtD
Clopidogrel—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000261	0.00144	CcSEcCtD
Clopidogrel—Hypersensitivity—Cisplatin—bone cancer	0.00026	0.00144	CcSEcCtD
Clopidogrel—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000259	0.00337	CbGpPWpGaD
Clopidogrel—Renal failure—Doxorubicin—bone cancer	0.000259	0.00143	CcSEcCtD
Clopidogrel—Erythema multiforme—Methotrexate—bone cancer	0.000258	0.00143	CcSEcCtD
Clopidogrel—Neuropathy peripheral—Doxorubicin—bone cancer	0.000258	0.00143	CcSEcCtD
Clopidogrel—Haemoglobin—Epirubicin—bone cancer	0.000257	0.00142	CcSEcCtD
Clopidogrel—Stomatitis—Doxorubicin—bone cancer	0.000257	0.00142	CcSEcCtD
Clopidogrel—Rhinitis—Epirubicin—bone cancer	0.000256	0.00141	CcSEcCtD
Clopidogrel—Conjunctivitis—Doxorubicin—bone cancer	0.000256	0.00141	CcSEcCtD
Clopidogrel—Urinary tract infection—Doxorubicin—bone cancer	0.000256	0.00141	CcSEcCtD
Clopidogrel—CYP2C19—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000256	0.00333	CbGpPWpGaD
Clopidogrel—Haemorrhage—Epirubicin—bone cancer	0.000255	0.00141	CcSEcCtD
Clopidogrel—Hepatitis—Epirubicin—bone cancer	0.000255	0.00141	CcSEcCtD
Clopidogrel—Eye disorder—Methotrexate—bone cancer	0.000255	0.00141	CcSEcCtD
Clopidogrel—P2RY12—Hemostasis—SPARC—bone cancer	0.000255	0.00332	CbGpPWpGaD
Clopidogrel—Tinnitus—Methotrexate—bone cancer	0.000254	0.00141	CcSEcCtD
Clopidogrel—Hypoaesthesia—Epirubicin—bone cancer	0.000254	0.0014	CcSEcCtD
Clopidogrel—Asthenia—Cisplatin—bone cancer	0.000254	0.0014	CcSEcCtD
Clopidogrel—Urinary tract disorder—Epirubicin—bone cancer	0.000252	0.00139	CcSEcCtD
Clopidogrel—Oedema peripheral—Epirubicin—bone cancer	0.000252	0.00139	CcSEcCtD
Clopidogrel—Haematuria—Doxorubicin—bone cancer	0.000251	0.00139	CcSEcCtD
Clopidogrel—Urethral disorder—Epirubicin—bone cancer	0.00025	0.00138	CcSEcCtD
Clopidogrel—CYP1A2—Tryptophan metabolism—CYP3A4—bone cancer	0.00025	0.00325	CbGpPWpGaD
Clopidogrel—Hepatobiliary disease—Doxorubicin—bone cancer	0.000249	0.00137	CcSEcCtD
Clopidogrel—Epistaxis—Doxorubicin—bone cancer	0.000248	0.00137	CcSEcCtD
Clopidogrel—Angiopathy—Methotrexate—bone cancer	0.000248	0.00137	CcSEcCtD
Clopidogrel—Sinusitis—Doxorubicin—bone cancer	0.000247	0.00136	CcSEcCtD
Clopidogrel—Immune system disorder—Methotrexate—bone cancer	0.000247	0.00136	CcSEcCtD
Clopidogrel—Visual impairment—Epirubicin—bone cancer	0.000246	0.00136	CcSEcCtD
Clopidogrel—Mediastinal disorder—Methotrexate—bone cancer	0.000246	0.00136	CcSEcCtD
Clopidogrel—Agranulocytosis—Doxorubicin—bone cancer	0.000246	0.00136	CcSEcCtD
Clopidogrel—Diarrhoea—Cisplatin—bone cancer	0.000242	0.00134	CcSEcCtD
Clopidogrel—Erythema multiforme—Epirubicin—bone cancer	0.000241	0.00133	CcSEcCtD
Clopidogrel—P2RY12—Signaling by GPCR—GRM4—bone cancer	0.000239	0.00312	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—RGS1—bone cancer	0.000239	0.00312	CbGpPWpGaD
Clopidogrel—Mental disorder—Methotrexate—bone cancer	0.000239	0.00132	CcSEcCtD
Clopidogrel—Eye disorder—Epirubicin—bone cancer	0.000239	0.00132	CcSEcCtD
Clopidogrel—Tinnitus—Epirubicin—bone cancer	0.000238	0.00132	CcSEcCtD
Clopidogrel—Malnutrition—Methotrexate—bone cancer	0.000238	0.00131	CcSEcCtD
Clopidogrel—Haemoglobin—Doxorubicin—bone cancer	0.000238	0.00131	CcSEcCtD
Clopidogrel—Rhinitis—Doxorubicin—bone cancer	0.000237	0.00131	CcSEcCtD
Clopidogrel—Hepatitis—Doxorubicin—bone cancer	0.000236	0.00131	CcSEcCtD
Clopidogrel—Haemorrhage—Doxorubicin—bone cancer	0.000236	0.00131	CcSEcCtD
Clopidogrel—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000236	0.00308	CbGpPWpGaD
Clopidogrel—CYP2C8—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000235	0.00306	CbGpPWpGaD
Clopidogrel—Hypoaesthesia—Doxorubicin—bone cancer	0.000235	0.0013	CcSEcCtD
Clopidogrel—Urinary tract disorder—Doxorubicin—bone cancer	0.000233	0.00129	CcSEcCtD
Clopidogrel—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000233	0.00304	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—GNA11—bone cancer	0.000233	0.00303	CbGpPWpGaD
Clopidogrel—Oedema peripheral—Doxorubicin—bone cancer	0.000233	0.00129	CcSEcCtD
Clopidogrel—Angiopathy—Epirubicin—bone cancer	0.000232	0.00128	CcSEcCtD
Clopidogrel—Urethral disorder—Doxorubicin—bone cancer	0.000232	0.00128	CcSEcCtD
Clopidogrel—Immune system disorder—Epirubicin—bone cancer	0.000231	0.00127	CcSEcCtD
Clopidogrel—Mediastinal disorder—Epirubicin—bone cancer	0.00023	0.00127	CcSEcCtD
Clopidogrel—Back pain—Methotrexate—bone cancer	0.00023	0.00127	CcSEcCtD
Clopidogrel—P2RY12—GPCR downstream signaling—GRM1—bone cancer	0.000228	0.00297	CbGpPWpGaD
Clopidogrel—Visual impairment—Doxorubicin—bone cancer	0.000228	0.00126	CcSEcCtD
Clopidogrel—Vomiting—Cisplatin—bone cancer	0.000225	0.00124	CcSEcCtD
Clopidogrel—Mental disorder—Epirubicin—bone cancer	0.000224	0.00124	CcSEcCtD
Clopidogrel—Erythema multiforme—Doxorubicin—bone cancer	0.000223	0.00123	CcSEcCtD
Clopidogrel—Rash—Cisplatin—bone cancer	0.000223	0.00123	CcSEcCtD
Clopidogrel—Dermatitis—Cisplatin—bone cancer	0.000223	0.00123	CcSEcCtD
Clopidogrel—Malnutrition—Epirubicin—bone cancer	0.000222	0.00123	CcSEcCtD
Clopidogrel—Eye disorder—Doxorubicin—bone cancer	0.000221	0.00122	CcSEcCtD
Clopidogrel—Tinnitus—Doxorubicin—bone cancer	0.00022	0.00122	CcSEcCtD
Clopidogrel—Anaemia—Methotrexate—bone cancer	0.00022	0.00121	CcSEcCtD
Clopidogrel—Flatulence—Epirubicin—bone cancer	0.000219	0.00121	CcSEcCtD
Clopidogrel—Back pain—Epirubicin—bone cancer	0.000215	0.00119	CcSEcCtD
Clopidogrel—Angiopathy—Doxorubicin—bone cancer	0.000214	0.00118	CcSEcCtD
Clopidogrel—Muscle spasms—Epirubicin—bone cancer	0.000214	0.00118	CcSEcCtD
Clopidogrel—Immune system disorder—Doxorubicin—bone cancer	0.000213	0.00118	CcSEcCtD
Clopidogrel—Vertigo—Methotrexate—bone cancer	0.000213	0.00118	CcSEcCtD
Clopidogrel—Mediastinal disorder—Doxorubicin—bone cancer	0.000213	0.00118	CcSEcCtD
Clopidogrel—Leukopenia—Methotrexate—bone cancer	0.000213	0.00117	CcSEcCtD
Clopidogrel—P2RY12—Hemostasis—IL3—bone cancer	0.000211	0.00275	CbGpPWpGaD
Clopidogrel—CYP2C19—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00021	0.00273	CbGpPWpGaD
Clopidogrel—Nausea—Cisplatin—bone cancer	0.00021	0.00116	CcSEcCtD
Clopidogrel—P2RY12—Signaling by GPCR—GRM1—bone cancer	0.000207	0.0027	CbGpPWpGaD
Clopidogrel—Cough—Methotrexate—bone cancer	0.000207	0.00114	CcSEcCtD
Clopidogrel—Mental disorder—Doxorubicin—bone cancer	0.000207	0.00114	CcSEcCtD
Clopidogrel—Malnutrition—Doxorubicin—bone cancer	0.000206	0.00114	CcSEcCtD
Clopidogrel—Anaemia—Epirubicin—bone cancer	0.000206	0.00113	CcSEcCtD
Clopidogrel—Flatulence—Doxorubicin—bone cancer	0.000203	0.00112	CcSEcCtD
Clopidogrel—Arthralgia—Methotrexate—bone cancer	0.000202	0.00112	CcSEcCtD
Clopidogrel—Chest pain—Methotrexate—bone cancer	0.000202	0.00112	CcSEcCtD
Clopidogrel—Myalgia—Methotrexate—bone cancer	0.000202	0.00112	CcSEcCtD
Clopidogrel—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000202	0.00263	CbGpPWpGaD
Clopidogrel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000201	0.00111	CcSEcCtD
Clopidogrel—Vertigo—Epirubicin—bone cancer	0.0002	0.0011	CcSEcCtD
Clopidogrel—Syncope—Epirubicin—bone cancer	0.000199	0.0011	CcSEcCtD
Clopidogrel—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000199	0.00259	CbGpPWpGaD
Clopidogrel—Leukopenia—Epirubicin—bone cancer	0.000199	0.0011	CcSEcCtD
Clopidogrel—Back pain—Doxorubicin—bone cancer	0.000199	0.0011	CcSEcCtD
Clopidogrel—Muscle spasms—Doxorubicin—bone cancer	0.000198	0.00109	CcSEcCtD
Clopidogrel—Palpitations—Epirubicin—bone cancer	0.000196	0.00109	CcSEcCtD
Clopidogrel—Confusional state—Methotrexate—bone cancer	0.000196	0.00108	CcSEcCtD
Clopidogrel—Loss of consciousness—Epirubicin—bone cancer	0.000195	0.00108	CcSEcCtD
Clopidogrel—Cough—Epirubicin—bone cancer	0.000194	0.00107	CcSEcCtD
Clopidogrel—Anaphylactic shock—Methotrexate—bone cancer	0.000194	0.00107	CcSEcCtD
Clopidogrel—Infection—Methotrexate—bone cancer	0.000193	0.00106	CcSEcCtD
Clopidogrel—Hypertension—Epirubicin—bone cancer	0.000192	0.00106	CcSEcCtD
Clopidogrel—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000191	0.00249	CbGpPWpGaD
Clopidogrel—Nervous system disorder—Methotrexate—bone cancer	0.00019	0.00105	CcSEcCtD
Clopidogrel—Anaemia—Doxorubicin—bone cancer	0.00019	0.00105	CcSEcCtD
Clopidogrel—Myalgia—Epirubicin—bone cancer	0.000189	0.00105	CcSEcCtD
Clopidogrel—Arthralgia—Epirubicin—bone cancer	0.000189	0.00105	CcSEcCtD
Clopidogrel—Chest pain—Epirubicin—bone cancer	0.000189	0.00105	CcSEcCtD
Clopidogrel—Anxiety—Epirubicin—bone cancer	0.000189	0.00104	CcSEcCtD
Clopidogrel—Skin disorder—Methotrexate—bone cancer	0.000188	0.00104	CcSEcCtD
Clopidogrel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000188	0.00104	CcSEcCtD
Clopidogrel—Vertigo—Doxorubicin—bone cancer	0.000185	0.00102	CcSEcCtD
Clopidogrel—Syncope—Doxorubicin—bone cancer	0.000184	0.00102	CcSEcCtD
Clopidogrel—Leukopenia—Doxorubicin—bone cancer	0.000184	0.00102	CcSEcCtD
Clopidogrel—Confusional state—Epirubicin—bone cancer	0.000183	0.00101	CcSEcCtD
Clopidogrel—Palpitations—Doxorubicin—bone cancer	0.000182	0.001	CcSEcCtD
Clopidogrel—Anaphylactic shock—Epirubicin—bone cancer	0.000181	0.001	CcSEcCtD
Clopidogrel—Oedema—Epirubicin—bone cancer	0.000181	0.001	CcSEcCtD
Clopidogrel—Hypotension—Methotrexate—bone cancer	0.000181	0.001	CcSEcCtD
Clopidogrel—Loss of consciousness—Doxorubicin—bone cancer	0.000181	0.000999	CcSEcCtD
Clopidogrel—Infection—Epirubicin—bone cancer	0.00018	0.000996	CcSEcCtD
Clopidogrel—Cough—Doxorubicin—bone cancer	0.00018	0.000991	CcSEcCtD
Clopidogrel—Shock—Epirubicin—bone cancer	0.000179	0.000986	CcSEcCtD
Clopidogrel—Nervous system disorder—Epirubicin—bone cancer	0.000178	0.000983	CcSEcCtD
Clopidogrel—Hypertension—Doxorubicin—bone cancer	0.000178	0.000981	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000177	0.000976	CcSEcCtD
Clopidogrel—Skin disorder—Epirubicin—bone cancer	0.000176	0.000973	CcSEcCtD
Clopidogrel—Insomnia—Methotrexate—bone cancer	0.000175	0.000969	CcSEcCtD
Clopidogrel—Chest pain—Doxorubicin—bone cancer	0.000175	0.000967	CcSEcCtD
Clopidogrel—Myalgia—Doxorubicin—bone cancer	0.000175	0.000967	CcSEcCtD
Clopidogrel—Arthralgia—Doxorubicin—bone cancer	0.000175	0.000967	CcSEcCtD
Clopidogrel—Anxiety—Doxorubicin—bone cancer	0.000175	0.000964	CcSEcCtD
Clopidogrel—Paraesthesia—Methotrexate—bone cancer	0.000174	0.000962	CcSEcCtD
Clopidogrel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000174	0.000961	CcSEcCtD
Clopidogrel—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.000173	0.00226	CbGpPWpGaD
Clopidogrel—Dyspnoea—Methotrexate—bone cancer	0.000173	0.000955	CcSEcCtD
Clopidogrel—Dyspepsia—Methotrexate—bone cancer	0.000171	0.000943	CcSEcCtD
Clopidogrel—Hypotension—Epirubicin—bone cancer	0.00017	0.000936	CcSEcCtD
Clopidogrel—Confusional state—Doxorubicin—bone cancer	0.000169	0.000935	CcSEcCtD
Clopidogrel—Oedema—Doxorubicin—bone cancer	0.000168	0.000927	CcSEcCtD
Clopidogrel—Anaphylactic shock—Doxorubicin—bone cancer	0.000168	0.000927	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Methotrexate—bone cancer	0.000167	0.000924	CcSEcCtD
Clopidogrel—Fatigue—Methotrexate—bone cancer	0.000167	0.000923	CcSEcCtD
Clopidogrel—Infection—Doxorubicin—bone cancer	0.000167	0.000921	CcSEcCtD
Clopidogrel—Pain—Methotrexate—bone cancer	0.000166	0.000916	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000165	0.000913	CcSEcCtD
Clopidogrel—Shock—Doxorubicin—bone cancer	0.000165	0.000912	CcSEcCtD
Clopidogrel—Nervous system disorder—Doxorubicin—bone cancer	0.000165	0.000909	CcSEcCtD
Clopidogrel—Insomnia—Epirubicin—bone cancer	0.000164	0.000906	CcSEcCtD
Clopidogrel—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000164	0.00213	CbGpPWpGaD
Clopidogrel—Skin disorder—Doxorubicin—bone cancer	0.000163	0.000901	CcSEcCtD
Clopidogrel—Paraesthesia—Epirubicin—bone cancer	0.000163	0.0009	CcSEcCtD
Clopidogrel—Dyspnoea—Epirubicin—bone cancer	0.000162	0.000893	CcSEcCtD
Clopidogrel—Feeling abnormal—Methotrexate—bone cancer	0.00016	0.000882	CcSEcCtD
Clopidogrel—Dyspepsia—Epirubicin—bone cancer	0.00016	0.000882	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Methotrexate—bone cancer	0.000159	0.000876	CcSEcCtD
Clopidogrel—Hypotension—Doxorubicin—bone cancer	0.000157	0.000866	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Epirubicin—bone cancer	0.000157	0.000865	CcSEcCtD
Clopidogrel—Fatigue—Epirubicin—bone cancer	0.000156	0.000864	CcSEcCtD
Clopidogrel—Pain—Epirubicin—bone cancer	0.000155	0.000857	CcSEcCtD
Clopidogrel—Constipation—Epirubicin—bone cancer	0.000155	0.000857	CcSEcCtD
Clopidogrel—Urticaria—Methotrexate—bone cancer	0.000154	0.000851	CcSEcCtD
Clopidogrel—Abdominal pain—Methotrexate—bone cancer	0.000153	0.000847	CcSEcCtD
Clopidogrel—Body temperature increased—Methotrexate—bone cancer	0.000153	0.000847	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000153	0.000845	CcSEcCtD
Clopidogrel—Insomnia—Doxorubicin—bone cancer	0.000152	0.000839	CcSEcCtD
Clopidogrel—Paraesthesia—Doxorubicin—bone cancer	0.000151	0.000833	CcSEcCtD
Clopidogrel—Dyspnoea—Doxorubicin—bone cancer	0.00015	0.000827	CcSEcCtD
Clopidogrel—Feeling abnormal—Epirubicin—bone cancer	0.00015	0.000826	CcSEcCtD
Clopidogrel—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	0.000149	0.00194	CbGpPWpGaD
Clopidogrel—Gastrointestinal pain—Epirubicin—bone cancer	0.000148	0.000819	CcSEcCtD
Clopidogrel—Dyspepsia—Doxorubicin—bone cancer	0.000148	0.000816	CcSEcCtD
Clopidogrel—CYP2B6—Biological oxidations—CYP3A4—bone cancer	0.000148	0.00192	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR downstream signaling—GNA11—bone cancer	0.000147	0.00192	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—SMO—bone cancer	0.000146	0.0019	CbGpPWpGaD
Clopidogrel—CYP2B6—Metapathway biotransformation—CYP3A4—bone cancer	0.000146	0.0019	CbGpPWpGaD
Clopidogrel—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000145	0.000801	CcSEcCtD
Clopidogrel—Fatigue—Doxorubicin—bone cancer	0.000145	0.000799	CcSEcCtD
Clopidogrel—CYP3A5—Biological oxidations—CYP3A4—bone cancer	0.000144	0.00188	CbGpPWpGaD
Clopidogrel—Urticaria—Epirubicin—bone cancer	0.000144	0.000796	CcSEcCtD
Clopidogrel—Pain—Doxorubicin—bone cancer	0.000144	0.000793	CcSEcCtD
Clopidogrel—Constipation—Doxorubicin—bone cancer	0.000144	0.000793	CcSEcCtD
Clopidogrel—Abdominal pain—Epirubicin—bone cancer	0.000143	0.000792	CcSEcCtD
Clopidogrel—Body temperature increased—Epirubicin—bone cancer	0.000143	0.000792	CcSEcCtD
Clopidogrel—Hypersensitivity—Methotrexate—bone cancer	0.000143	0.000789	CcSEcCtD
Clopidogrel—CYP3A5—Metapathway biotransformation—CYP3A4—bone cancer	0.000142	0.00185	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000142	0.00185	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—RGS1—bone cancer	0.000141	0.00184	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—GRM4—bone cancer	0.000141	0.00184	CbGpPWpGaD
Clopidogrel—Asthenia—Methotrexate—bone cancer	0.000139	0.000768	CcSEcCtD
Clopidogrel—P2RY12—Hemostasis—PLAU—bone cancer	0.000138	0.0018	CbGpPWpGaD
Clopidogrel—Feeling abnormal—Doxorubicin—bone cancer	0.000138	0.000764	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Doxorubicin—bone cancer	0.000137	0.000758	CcSEcCtD
Clopidogrel—Pruritus—Methotrexate—bone cancer	0.000137	0.000758	CcSEcCtD
Clopidogrel—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	0.000135	0.00175	CbGpPWpGaD
Clopidogrel—Hypersensitivity—Epirubicin—bone cancer	0.000134	0.000738	CcSEcCtD
Clopidogrel—P2RY12—Signaling by GPCR—GNA11—bone cancer	0.000134	0.00174	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR downstream signaling—IL3—bone cancer	0.000133	0.00174	CbGpPWpGaD
Clopidogrel—Urticaria—Doxorubicin—bone cancer	0.000133	0.000737	CcSEcCtD
Clopidogrel—CYP2C19—Arachidonic acid metabolism—PTGS2—bone cancer	0.000133	0.00173	CbGpPWpGaD
Clopidogrel—Abdominal pain—Doxorubicin—bone cancer	0.000133	0.000733	CcSEcCtD
Clopidogrel—Body temperature increased—Doxorubicin—bone cancer	0.000133	0.000733	CcSEcCtD
Clopidogrel—Diarrhoea—Methotrexate—bone cancer	0.000133	0.000733	CcSEcCtD
Clopidogrel—Asthenia—Epirubicin—bone cancer	0.00013	0.000719	CcSEcCtD
Clopidogrel—Pruritus—Epirubicin—bone cancer	0.000128	0.000709	CcSEcCtD
Clopidogrel—Dizziness—Methotrexate—bone cancer	0.000128	0.000708	CcSEcCtD
Clopidogrel—CYP1A2—Phase II conjugation—GSTP1—bone cancer	0.000127	0.00165	CbGpPWpGaD
Clopidogrel—CYP2B6—Biological oxidations—GSTP1—bone cancer	0.000126	0.00164	CbGpPWpGaD
Clopidogrel—CYP2C8—Biological oxidations—CYP3A4—bone cancer	0.000125	0.00163	CbGpPWpGaD
Clopidogrel—CYP2B6—Metapathway biotransformation—GSTP1—bone cancer	0.000124	0.00162	CbGpPWpGaD
Clopidogrel—Diarrhoea—Epirubicin—bone cancer	0.000124	0.000686	CcSEcCtD
Clopidogrel—Hypersensitivity—Doxorubicin—bone cancer	0.000124	0.000683	CcSEcCtD
Clopidogrel—CYP3A5—Biological oxidations—GSTP1—bone cancer	0.000123	0.00161	CbGpPWpGaD
Clopidogrel—Vomiting—Methotrexate—bone cancer	0.000123	0.000681	CcSEcCtD
Clopidogrel—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	0.000123	0.00161	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—GRM1—bone cancer	0.000123	0.0016	CbGpPWpGaD
Clopidogrel—Rash—Methotrexate—bone cancer	0.000122	0.000675	CcSEcCtD
Clopidogrel—Dermatitis—Methotrexate—bone cancer	0.000122	0.000675	CcSEcCtD
Clopidogrel—CYP3A5—Metapathway biotransformation—GSTP1—bone cancer	0.000122	0.00158	CbGpPWpGaD
Clopidogrel—Headache—Methotrexate—bone cancer	0.000121	0.000671	CcSEcCtD
Clopidogrel—P2RY12—Signaling by GPCR—IL3—bone cancer	0.000121	0.00158	CbGpPWpGaD
Clopidogrel—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	0.000121	0.00158	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000121	0.00157	CbGpPWpGaD
Clopidogrel—Asthenia—Doxorubicin—bone cancer	0.00012	0.000665	CcSEcCtD
Clopidogrel—Dizziness—Epirubicin—bone cancer	0.00012	0.000663	CcSEcCtD
Clopidogrel—Pruritus—Doxorubicin—bone cancer	0.000119	0.000656	CcSEcCtD
Clopidogrel—Vomiting—Epirubicin—bone cancer	0.000115	0.000637	CcSEcCtD
Clopidogrel—Nausea—Methotrexate—bone cancer	0.000115	0.000636	CcSEcCtD
Clopidogrel—Diarrhoea—Doxorubicin—bone cancer	0.000115	0.000634	CcSEcCtD
Clopidogrel—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	0.000115	0.00149	CbGpPWpGaD
Clopidogrel—Rash—Epirubicin—bone cancer	0.000114	0.000632	CcSEcCtD
Clopidogrel—Dermatitis—Epirubicin—bone cancer	0.000114	0.000631	CcSEcCtD
Clopidogrel—Headache—Epirubicin—bone cancer	0.000114	0.000628	CcSEcCtD
Clopidogrel—CYP2C19—Biological oxidations—CYP3A4—bone cancer	0.000112	0.00145	CbGpPWpGaD
Clopidogrel—Dizziness—Doxorubicin—bone cancer	0.000111	0.000613	CcSEcCtD
Clopidogrel—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	0.000111	0.00144	CbGpPWpGaD
Clopidogrel—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	0.00011	0.00143	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.00011	0.00143	CbGpPWpGaD
Clopidogrel—Nausea—Epirubicin—bone cancer	0.000108	0.000595	CcSEcCtD
Clopidogrel—CYP2C8—Biological oxidations—GSTP1—bone cancer	0.000107	0.00139	CbGpPWpGaD
Clopidogrel—Vomiting—Doxorubicin—bone cancer	0.000107	0.00059	CcSEcCtD
Clopidogrel—Rash—Doxorubicin—bone cancer	0.000106	0.000585	CcSEcCtD
Clopidogrel—Dermatitis—Doxorubicin—bone cancer	0.000106	0.000584	CcSEcCtD
Clopidogrel—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	0.000105	0.00137	CbGpPWpGaD
Clopidogrel—Headache—Doxorubicin—bone cancer	0.000105	0.000581	CcSEcCtD
Clopidogrel—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	0.000103	0.00135	CbGpPWpGaD
Clopidogrel—CYP2C9—Biological oxidations—CYP3A4—bone cancer	0.000102	0.00132	CbGpPWpGaD
Clopidogrel—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	0.0001	0.00131	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.0001	0.0013	CbGpPWpGaD
Clopidogrel—Nausea—Doxorubicin—bone cancer	9.97e-05	0.000551	CcSEcCtD
Clopidogrel—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	9.97e-05	0.0013	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	9.87e-05	0.00129	CbGpPWpGaD
Clopidogrel—CYP2C19—Biological oxidations—GSTP1—bone cancer	9.54e-05	0.00124	CbGpPWpGaD
Clopidogrel—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	9.41e-05	0.00123	CbGpPWpGaD
Clopidogrel—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	9.36e-05	0.00122	CbGpPWpGaD
Clopidogrel—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	8.85e-05	0.00115	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—NDUFA12—bone cancer	8.85e-05	0.00115	CbGpPWpGaD
Clopidogrel—CYP2C9—Biological oxidations—GSTP1—bone cancer	8.7e-05	0.00113	CbGpPWpGaD
Clopidogrel—CYP1A2—Biological oxidations—CYP3A4—bone cancer	8.69e-05	0.00113	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—NDUFA12—bone cancer	8.65e-05	0.00113	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—SMO—bone cancer	8.63e-05	0.00112	CbGpPWpGaD
Clopidogrel—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	8.58e-05	0.00112	CbGpPWpGaD
Clopidogrel—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	8.57e-05	0.00112	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	8.37e-05	0.00109	CbGpPWpGaD
Clopidogrel—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	8.35e-05	0.00109	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—GNA11—bone cancer	7.89e-05	0.00103	CbGpPWpGaD
Clopidogrel—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	7.84e-05	0.00102	CbGpPWpGaD
Clopidogrel—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	7.84e-05	0.00102	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—NDUFA12—bone cancer	7.49e-05	0.000976	CbGpPWpGaD
Clopidogrel—CYP1A2—Biological oxidations—GSTP1—bone cancer	7.43e-05	0.000968	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—ATF1—bone cancer	7.34e-05	0.000956	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—NT5C3A—bone cancer	7.33e-05	0.000955	CbGpPWpGaD
Clopidogrel—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	7.33e-05	0.000955	CbGpPWpGaD
Clopidogrel—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	7.2e-05	0.000938	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—NT5C3A—bone cancer	7.16e-05	0.000933	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—IL3—bone cancer	7.16e-05	0.000932	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—NDUFA12—bone cancer	6.68e-05	0.000871	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—NDUFA12—bone cancer	6.52e-05	0.00085	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	6.21e-05	0.000808	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—NT5C3A—bone cancer	6.21e-05	0.000808	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—TGFBR2—bone cancer	6.12e-05	0.000797	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—NDUFA12—bone cancer	6.1e-05	0.000794	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—IGF1R—bone cancer	5.76e-05	0.00075	CbGpPWpGaD
Clopidogrel—CYP3A4—Biological oxidations—GSTP1—bone cancer	5.74e-05	0.000747	CbGpPWpGaD
Clopidogrel—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	5.66e-05	0.000737	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—TP53—bone cancer	5.57e-05	0.000725	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—NT5C3A—bone cancer	5.54e-05	0.000721	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—NT5C3A—bone cancer	5.41e-05	0.000704	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—NDUFA12—bone cancer	5.21e-05	0.000678	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—NT5C3A—bone cancer	5.05e-05	0.000658	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	4.6e-05	0.000599	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	4.44e-05	0.000578	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—NT5C3A—bone cancer	4.32e-05	0.000562	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—KIT—bone cancer	4.18e-05	0.000544	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—NDUFA12—bone cancer	4.02e-05	0.000524	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	4e-05	0.000521	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—BRAF—bone cancer	3.93e-05	0.000511	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—EGFR—bone cancer	3.81e-05	0.000496	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—NT5C3A—bone cancer	3.33e-05	0.000434	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—MDM2—bone cancer	3.29e-05	0.000428	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—ENO2—bone cancer	3.21e-05	0.000418	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	3.14e-05	0.00041	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—ENO2—bone cancer	3.14e-05	0.000409	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—DHFR—bone cancer	2.98e-05	0.000388	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—DHFR—bone cancer	2.91e-05	0.000379	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—JUN—bone cancer	2.86e-05	0.000372	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—GNA11—bone cancer	2.78e-05	0.000363	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—MMP9—bone cancer	2.78e-05	0.000362	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—GNA11—bone cancer	2.72e-05	0.000354	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—ENO2—bone cancer	2.72e-05	0.000354	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	2.64e-05	0.000344	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—CYP3A4—bone cancer	2.52e-05	0.000329	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—DHFR—bone cancer	2.52e-05	0.000328	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—CYP3A4—bone cancer	2.47e-05	0.000321	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—ENO2—bone cancer	2.43e-05	0.000316	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—ENO2—bone cancer	2.37e-05	0.000308	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—GNA11—bone cancer	2.36e-05	0.000307	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—DHFR—bone cancer	2.25e-05	0.000293	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—EGFR—bone cancer	2.25e-05	0.000293	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—ENO2—bone cancer	2.21e-05	0.000288	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—DHFR—bone cancer	2.2e-05	0.000286	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—GSTP1—bone cancer	2.16e-05	0.000281	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—CYP3A4—bone cancer	2.14e-05	0.000278	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.13e-05	0.000277	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—GSTP1—bone cancer	2.11e-05	0.000275	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—GNA11—bone cancer	2.1e-05	0.000274	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—GNA11—bone cancer	2.05e-05	0.000267	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—DHFR—bone cancer	2.05e-05	0.000267	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—GNA11—bone cancer	1.92e-05	0.00025	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—CYP3A4—bone cancer	1.91e-05	0.000248	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.9e-05	0.000247	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—ENO2—bone cancer	1.89e-05	0.000246	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—TP53—bone cancer	1.89e-05	0.000246	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—CYP3A4—bone cancer	1.86e-05	0.000242	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—GSTP1—bone cancer	1.83e-05	0.000238	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—DHFR—bone cancer	1.75e-05	0.000228	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—CYP3A4—bone cancer	1.74e-05	0.000227	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.73e-05	0.000225	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—GNA11—bone cancer	1.64e-05	0.000214	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—GSTP1—bone cancer	1.63e-05	0.000212	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—GSTP1—bone cancer	1.59e-05	0.000207	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—GSTP1—bone cancer	1.49e-05	0.000194	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—CYP3A4—bone cancer	1.49e-05	0.000194	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.48e-05	0.000193	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—ENO2—bone cancer	1.46e-05	0.00019	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—DHFR—bone cancer	1.35e-05	0.000176	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—GSTP1—bone cancer	1.27e-05	0.000166	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—GNA11—bone cancer	1.27e-05	0.000165	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PTGS2—bone cancer	1.12e-05	0.000146	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PTGS2—bone cancer	1.09e-05	0.000142	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—GSTP1—bone cancer	9.81e-06	0.000128	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PTGS2—bone cancer	9.47e-06	0.000123	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PTGS2—bone cancer	8.45e-06	0.00011	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PTGS2—bone cancer	8.25e-06	0.000107	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PTGS2—bone cancer	7.71e-06	0.0001	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PTGS2—bone cancer	6.58e-06	8.58e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PTGS2—bone cancer	5.08e-06	6.62e-05	CbGpPWpGaD
